Furthermore, cutaneous AEs are related to T-cell activation mediated by the blockade of PD-1 (or the PD-L1 ligand) and CTLA-4 receptors as well as the cross-reactivity between T cells directed against a tumor and T cells directed against normal tissue antigens [67]. This evidence concerns the gene CD274 and neoplasm.